Synergistic antibacterial effect between silybin and N,N′-dicyclohexylcarbodiimide in clinical Pseudomonas aeruginosa isolates

[1]  Y. Seu,et al.  Candicidal action of resveratrol isolated from grapes on human pathogenic yeast C. albicans. , 2007, Journal of microbiology and biotechnology.

[2]  Seung-Il Jeong,et al.  Antibacterial activity of sophoraflavanone G isolated from the roots of Sophora flavescens. , 2007, Journal of microbiology and biotechnology.

[3]  A. Driessen,et al.  Proton motive force-dependent Hoechst 33342 transport by the ABC transporter LmrA of Lactococcus lactis. , 2005, Biochemistry.

[4]  V. Křen,et al.  Silybin and silymarin--new effects and applications. , 2005, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.

[5]  D. Hooper.  Efflux pumps and nosocomial antibiotic resistance: a primer for hospital epidemiologists. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  Jue Chen,et al.  ATP-binding cassette transporters in bacteria. , 2004, Annual review of biochemistry.

[7]  F. Denizot,et al.  Characterization of YvcC (BmrA), a multidrug ABC transporter constitutively expressed in Bacillus subtilis. , 2004, Biochemistry.

[8]  R. Agarwal,et al.  Synergistic anti-cancer effects of silibinin with conventional cytotoxic agents doxorubicin, cisplatin and carboplatin against human breast carcinoma MCF-7 and MDA-MB468 cells. , 2004, Oncology reports.

[9]  R. Agarwal,et al.  Prostate cancer prevention by silibinin. , 2004, Current cancer drug targets.

[10]  T. Tsuchiya,et al.  EfrAB, an ABC Multidrug Efflux Pump in Enterococcus faecalis , 2003, Antimicrobial Agents and Chemotherapy.

[11]  H. Nikaido.  Molecular Basis of Bacterial Outer Membrane Permeability Revisited , 2003, Microbiology and Molecular Biology Reviews.

[12]  R. Agarwal,et al.  Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells , 2003, Oncogene.

[13]  M. Bonten,et al.  Epidemic and Nonepidemic Multidrug-Resistant Enterococcus faecium , 2003, Emerging infectious diseases.

[14]  Seong-Cheol Park,et al.  Gram-positive bacteria specific properties of silybin derived fromSilybum marianum , 2003, Archives of pharmacal research.

[15]  R. Agarwal,et al.  Silibinin induces growth inhibition and apoptotic cell death in human lung carcinoma cells. , 2003, Anticancer research.

[16]  B. Poolman,et al.  ABC transporters: one, two or four extracytoplasmic substrate‐binding sites? , 2002, EMBO reports.

[17]  G. Tegos,et al.  Multidrug Pump Inhibitors Uncover Remarkable Activity of Plant Antimicrobials , 2002, Antimicrobial Agents and Chemotherapy.

[18]  L. Grinius,et al.  NorA Functions as a Multidrug Efflux Protein in both Cytoplasmic Membrane Vesicles and Reconstituted Proteoliposomes , 2002, Journal of bacteriology.

[19]  L. Valera,et al.  Synergistic Activities of Gatifloxacin in Combination with Other Antimicrobial Agents against Pseudomonas aeruginosa and Related Species , 2001, Antimicrobial Agents and Chemotherapy.

[20]  H. Ceri,et al.  Multidrug Efflux Pumps: Expression Patterns and Contribution to Antibiotic Resistance in Pseudomonas aeruginosa Biofilms , 2001, Antimicrobial Agents and Chemotherapy.

[21]  K. Lewis.  In search of natural substrates and inhibitors of MDR pumps. , 2001, Journal of molecular microbiology and biotechnology.

[22]  J. M. Pérez-Victoria,et al.  High-Affinity Binding of Silybin Derivatives to the Nucleotide-Binding Domain of a Leishmania tropicaP-Glycoprotein-Like Transporter and Chemosensitization of a Multidrug-Resistant Parasite to Daunomycin , 2001, Antimicrobial Agents and Chemotherapy.

[23]  K. Lewis,et al.  5'-Methoxyhydnocarpin-D and pheophorbide A: Berberis species components that potentiate berberine growth inhibition of resistant Staphylococcus aureus. , 2000, Journal of natural products.

[24]  B. D. Gupta,et al.  Anti-inflammatory and anti-arthritic activities of silymarin acting through inhibition of 5-lipoxygenase. , 2000, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[25]  S. Gibbons,et al.  The effect of reserpine, a modulator of multidrug efflux pumps, on the in vitro activity of tetracycline against clinical isolates of methicillin resistant Staphylococcus aureus (MRSA) possessing the tet(K) determinant , 2000, Phytotherapy research : PTR.

[26]  T. Renau,et al.  Inhibitors of efflux pumps in Pseudomonas aeruginosa potentiate the activity of the fluoroquinolone antibacterial levofloxacin. , 1999, Journal of medicinal chemistry.

[27]  P. Gonçalves,et al.  Synaptic vesicle Ca2+/H+ antiport: dependence on the proton electrochemical gradient. , 1999, Brain research. Molecular brain research.

[28]  H. Nikaido,et al.  Bypassing the periplasm: reconstitution of the AcrAB multidrug efflux pump of Escherichia coli. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[29]  H. Steen,et al.  Staining of Escherichia coli for flow cytometry: influx and efflux of ethidium bromide. , 1994, Cytometry.

[30]  K. Lewis,et al.  Multidrug resistance pumps in bacteria: variations on a theme. , 1994, Trends in biochemical sciences.

[31]  K. Lewis,et al.  Emr, an Escherichia coli locus for multidrug resistance. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[32]  S. Levy,et al.  Active efflux mechanisms for antimicrobial resistance , 1992, Antimicrobial Agents and Chemotherapy.

[33]  S. Grinstein,et al.  A vacuolar type H(+)-ATPase regulates cytoplasmic pH in murine macrophages. , 1990, The Journal of biological chemistry.

[34]  Michael M. Gottesman,et al.  Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells , 1986, Cell.

[35]  R. Hancock,et al.  Compounds which increase the permeability of the Pseudomonas aeruginosa outer membrane , 1984, Antimicrobial Agents and Chemotherapy.

[36]  J. Costerton,et al.  Tris(hydroxymethyl)aminomethane buffer modification of Escherichia coli outer membrane permeability , 1981, Journal of bacteriology.

[37]  S. Levy,et al.  Active efflux of tetracycline encoded by four genetically different tetracycline resistance determinants in Escherichia coli. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[38]  P. Linnett,et al.  [59] Inhibitors of the ATP synthetase systems☆ , 1979 .

[39]  L. Leive.  Actinomycin sensitivity in Escherichiacoli produced by EDTA , 1965 .